ETD Collection

Permanent URI for this collectionhttps://wiredspace.wits.ac.za/handle/10539/104


Please note: Digitised content is made available at the best possible quality range, taking into consideration file size and the condition of the original item. These restrictions may sometimes affect the quality of the final published item. For queries regarding content of ETD collection please contact IR specialists by email : IR specialists or Tel : 011 717 4652 / 1954

Follow the link below for important information about Electronic Theses and Dissertations (ETD)

Library Guide about ETD

Browse

Filters

20181

Settings

Author: search.filters.author.Gu, LiangSubject: search.filters.subject.Breast--Cancer

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Cholesteryl ester transfer protein (CETP) as a possible drug-resistance marker in breast cancer
    (2018) Gu, Liang
    Hormone responsive breast cancer (BC) is the most common BC and relies on steroid hormones for cell proliferation and survival, therefore endocrine therapy; Tamoxifen (TAM), serves as the main therapeutic strategy in treating hormone receptor positive BC. Despite the use of TAM for over four decades, overcoming drug resistance remains challenging. Due to the fact that steroid hormones are derived from cholesterol and evidently, increased level of cholesterol is associated with cancer progression, in this research, we investigated the effect of reducing intracellular cholesterol as a possible alternative method to induce cell death in BC cells. An important protein involved in cholesterol homeostasis is the Cholesteryl Ester Transfer Protein (CETP). CETP maintains cholesterol homeostasis by storing cholesteryl esters (CEs) in lipid droplets. The intracellular accumulation of CEs leads to aggressive cancer development and drug resistance. Therefore, we aim to investigate whether CETP can possibly be used as a drug-resistance marker in BC. This study has shown that knocking-down CETP resulted in increase in apoptosis in MCF-7 cells when treated with TAM (by 10-40%) and various other drugs. Furthermore, CETP knock-down with the addition of a cholesterol-depleting agent increased apoptosis by 10 fold when compared to the non-transfected MCF-7 cells, possibly due to a decrease in CE content. Similar results were observed in MDA-MB-231 cells. Therefore, it was concluded that CETP could thus serve as a potential drug-resistance marker in cancer cells, more specifically BC. Furthermore, strategies targeting CETP could be used as a potential combination treatment for treating cancer.